Literature DB >> 25595923

Postoperative atrial fibrillation is not pulmonary vein dependent: results from a randomized trial.

Bob Kiaii1, Stephanie Fox2, Lindsay Chase2, Michaela Fernandes2, Larry W Stitt3, Ray Guo2, Mackenzie Quantz2, Michael W Chu2, Pavan Koka2, R Scott McClure2, F Neil McKenzie2, George J Klein3, Richard J Novick2, Allan C Skanes4.   

Abstract

BACKGROUND: Although often short-lived and self-limiting, postoperative atrial fibrillation (POAF) is a well-recognized postoperative complication of cardiac surgery and is associated with a 2-fold increase in cardiovascular mortality and morbidity.
OBJECTIVE: Our aim was to determine whether intraoperative bilateral pulmonary vein radiofrequency ablation decreases the incidence of POAF in patients undergoing coronary artery bypass grafting (CABG).
METHODS: A total of 175 patients undergoing CABG was prospectively randomized to undergo adjuvant bilateral radiofrequency pulmonary vein ablation in addition to CABG (group A; n = 89) or CABG alone (group B; n = 86). Intraoperative pulmonary vein isolation was confirmed by the inability to pace the heart via the pulmonary veins after ablation. All patients received postoperative β-blocker.
RESULTS: There was no difference in the incidence of POAF in the treatment group who underwent adjuvant pulmonary vein ablation (group A; 37.1%) compared with the control group who did not (group B; 36.1%) (P = .887). There were no differences in postoperative inotropic support, antiarrhythmic drug use, need for oral anticoagulation, and complication rates. The mean length of postoperative hospital stay was 8.2 ± 6.5 days in the ablation group and 6.7 ± 4.6 days in the control group (P < .001).
CONCLUSION: Adjuvant pulmonary vein isolation does not decrease the incidence of POAF or its clinical impact but increases the mean length of stay in the hospital. The mechanism of POAF does not appear to depend on the pulmonary veins.
Copyright © 2015 Heart Rhythm Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Ablation; Atrial fibrillation; Bypass; Electrophysiology; Surgery

Mesh:

Year:  2015        PMID: 25595923     DOI: 10.1016/j.hrthm.2015.01.014

Source DB:  PubMed          Journal:  Heart Rhythm        ISSN: 1547-5271            Impact factor:   6.343


  6 in total

Review 1.  New-onset atrial fibrillation: an update.

Authors:  Takeshi Omae; Eiichi Inada
Journal:  J Anesth       Date:  2018-03-09       Impact factor: 2.078

Review 2.  Electrophysiological Perspectives on Hybrid Ablation of Atrial Fibrillation.

Authors:  Faisal F Syed; Hakan Oral
Journal:  J Atr Fibrillation       Date:  2015-12-31

3.  Long Term Outcome of Postoperative Atrial Fibrillation After Cardiac Surgery-A Propensity Score-Matched Cohort Analysis.

Authors:  Jung-Chi Hsu; Chen-Yu Huang; Shu-Lin Chuang; Hsu-Yu Yu; Yih-Sharng Chen; Chih-Hsien Wang; Lian-Yu Lin
Journal:  Front Cardiovasc Med       Date:  2021-04-27

4.  Non-invasive evaluation of new-onset atrial fibrillation after cardiac surgery: a protocol for the BigMap study.

Authors:  Constantin Mork; Simon Adrian Amacher; Brigitta Gahl; Luca Koechlin; Jules Miazza; Thibault Schaeffer; Lena Schmuelling; Jens Bremerich; Denis Berdajs; Nadine Cueni; Michael Kühne; Christian Mueller; Stefan Osswald; Oliver Reuthebuch; Ulrich Schurr; Christian Sticherling; Andrea Kopp Lugli; Stephan Marsch; Hans Pargger; Martin Siegemund; Friedrich Eckstein; Alexa Hollinger; David Santer
Journal:  ESC Heart Fail       Date:  2022-04-19

5.  Editorial commentary: What can lung transplantation teach us about the mechanisms of atrial arrhythmias?

Authors:  Tina Baykaner; Albert J Rogers; Junaid A B Zaman; Sanjiv M Narayan
Journal:  Trends Cardiovasc Med       Date:  2017-08-30       Impact factor: 6.677

6.  Atrial Fibrillation Initiated by Early Afterdepolarization-Mediated Triggered Activity during Acute Oxidative Stress: Efficacy of Late Sodium Current Blockade.

Authors:  Arash Pezhouman; Hong Cao; Michael C Fishbein; Luiz Belardinelli; James N Weiss; Hrayr S Karagueuzian
Journal:  J Heart Health       Date:  2018-04-25
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.